Glox Therapeutics Limited

DataGardener
live
Small

Glox Therapeutics Limited

sc760230Private Limited With Share Capital

John Arbuthnott Building, Strathclyde University Of Pharma, Glasgow, G40RE
Incorporated

27/02/2023

Company Age

3 years

Directors

4

Employees

6

SIC Code

72110

Risk

low risk

Company Overview

Registration, classification & business activity

Glox Therapeutics Limited (sc760230) is a private limited with share capital incorporated on 27/02/2023 (3 years old) and registered in glasgow, G40RE. The company operates under SIC code 72110 - research and experimental development on biotechnology.

Glox therapeutics ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target gram-negative antimicrobial resistant (amr) pathogens.

Private Limited With Share Capital
SIC: 72110
Small
Incorporated 27/02/2023
G40RE
6 employees

Financial Overview

Total Assets

£935.0K

Liabilities

£459.0K

Net Assets

£476.1K

Cash

£816.1K

Key Metrics

6

Employees

4

Directors

8

Shareholders

Board of Directors

4

Import / Export

Imports
12 Months2
60 Months2
Exports
12 Months0
60 Months0

Risk Assessment

low risk

International Score

Future Factor

excellent

Performance Rating

Accounts

Typesmall company
Due Date30/09/2026
Filing Date09/09/2025
Latest Accounts31/12/2024

Trading Addresses

Central Mail Room, University Avenue, Glasgow, G128QQRegistered
John Arbuthnott Building, 161 Cathedral Street, Glasgow, G40RERegistered
11 University Avenue The Square, Glasgow, Lanarkshire, G128QQ
John Arbuthnott Building, 161 Cathedral Street, Glasgow, G40RERegistered

Related Companies

2

Contact

John Arbuthnott Building, Strathclyde University Of Pharma, Glasgow, G40RE